Proteasome-dependent regulation of p21(WAF1/CIP1) expression

被引:222
|
作者
Blagosklonny, MV
Wu, GS
Omura, S
ElDeiry, WS
机构
[1] UNIV PENN,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,HOWARD HUGHES MED INST,CTR CANC,PHILADELPHIA,PA 19104
[3] KITASATO INST,TOKYO 108,JAPAN
关键词
D O I
10.1006/bbrc.1996.1546
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteasome-dependent degradation of regulatory proteins is a known mechanism of cell cycle control. We found that the proteasome-specific inhibitor lactacystin (LC) induced expression of the cell cycle inhibitor p21(WAF1/CIP1) in human cancer cells regardless of their p53 status. Both wild-type (wt) p53 and p21 protein levels increased by two hours in wt p53 containing cells, whereas mutant (mt) p53 levels decreased and the increase in p21 levels was delayed to 6 hr following inhibition of proteolysis by LC in me p53 expressing cells. We found that wt but not mt p53 expressing cells increased p21 mRNA and p21-promoter reporter levels following LC exposure, suggesting transcriptional induction of p21. Inhibition of protein synthesis by cycloheximide demonstrated increased p21 protein half-life in the presence of LC in mutant p53 containing cells. p21 induction was correlated with the cytostatic effects of LC. The results suggest that p21 protein expression could be increased by transcriptional mechanisms as well as inhibition of proteolysis by LC. (C) 1996 Academic Press, Inc.
引用
收藏
页码:564 / 569
页数:6
相关论文
共 50 条
  • [1] p21(Waf1/cip1) expression
    Rees, JL
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (05) : 803 - 803
  • [2] Expression of p21(CIP1/WAF1) in chondrocytes
    Stewart, MC
    Farnum, CE
    McLeod, JN
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (03) : 199 - 204
  • [3] Regulation of p21(WAF1/CIP1) expression by p53-independent pathways
    Zeng, YX
    ElDeiry, WS
    [J]. ONCOGENE, 1996, 12 (07) : 1557 - 1564
  • [4] p21(WAF1/Cip1) expression in colorectal neoplasms.
    Roddey, G
    Ruan, S
    Stephens, LC
    Frazier, ML
    Glober, G
    Shen, Y
    Zhang, W
    Sinicrope, FA
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A645 - A645
  • [5] Regulation of p21(waf1/cip1) expression during normal myeloid differentiation.
    Steinman, RA
    Li, Y
    Goff, JP
    Yaroslavkiy, B
    Ball, E
    Kaplan, S
    [J]. BLOOD, 1996, 88 (10) : 2146 - 2146
  • [6] Posttranscriptional regulation of p21(WAF1/CIP1) expression in human breast carcinoma cells
    Li, XS
    Rishi, AK
    Shao, ZM
    Dawson, MI
    Jong, L
    Shroot, B
    Reichert, U
    Ordonez, J
    Fontana, JA
    [J]. CANCER RESEARCH, 1996, 56 (21) : 5055 - 5062
  • [7] Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
    Ito, Y
    Kobayashi, T
    Takeda, T
    Komoike, Y
    Wakasugi, E
    Tamaki, Y
    Tsujimoto, M
    Matsuura, N
    Monden, M
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (08) : 1269 - 1274
  • [8] Calcium dependent p21 cip1/waf1 stabilizer cyclin I (Ccni)
    Chu, Hsueh-Liang
    Chen, Tzu-Hsuan
    Yeh, Yi-Chen
    Tsai, Chuan-Mei
    Wu, Chang-You
    Svanidze, Anna
    Chang, Chia-Ching
    [J]. FASEB JOURNAL, 2008, 22
  • [9] p21(WAF1/CIP1) expression in benign and malignant soft tissue tumors
    Pindzola, JA
    Palazzo, JP
    Kovatich, AJ
    Tuma, B
    Nobel, M
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 54 - 54
  • [10] Analysis of p21(WAF1/CIP1) in primary bladder tumors
    Lacombe, L
    Orlow, I
    Silver, D
    Gerald, WL
    Fair, WR
    Reuter, VE
    CordonCardo, C
    [J]. ONCOLOGY RESEARCH, 1996, 8 (10-11) : 409 - 414